Industry Exposure - Medical DevicesOperating in the medical devices sector provides structural demand driven by healthcare spending, aging populations, and recurring capital replacement cycles. These industry characteristics support durable revenue opportunities and long-term market relevance independent of short-term cycles.

Positive Return On Equity (reported)A reported positive ROE indicates the company can generate accounting returns on its equity base; even though driven by negative equity, it signals operating leverage exists. If balance sheet repair occurs, the company could convert operating performance into sustainable shareholder returns.

Free Cash Flow Aligns With Net IncomeFCF matching net income suggests earnings are backed by cash flow rather than large non‑cash adjustments, which supports earnings quality. While flows are negative in absolute terms, parity reduces risk of hidden accruals and aids assessment of recovery trajectories.

Bears Say

Negative Stockholders' EquityLiabilities exceeding assets indicate impaired solvency and limited financial flexibility. Negative equity constrains access to debt/equity markets, raises default risk, and can force asset sales or dilutive capital raises, undermining long-term strategic investments.

Sustained Revenue DeclineA persistent top‑line decline reduces scale economies and pressures gross and operating margins. Losing revenue momentum in a device business weakens pricing power, increases per‑unit overhead, and makes investment in product development and commercialization harder to sustain.

Negative Operating And Free Cash FlowPersistent negative operating and free cash flows drain liquidity and force reliance on external financing. Over months, this limits R&D, regulatory submissions, and sales expansion, increases refinancing/dilution risk, and can materially impair long‑term competitiveness.

ASTI FAQ

What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?

Aquarius Surgical Technologies Inc. lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.

What is Aquarius Surgical Technologies Inc.’s market cap?

Aquarius Surgical Technologies Inc.’s market cap is C$413.99K.

When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?

Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Aug 03, 2026 which is in 139 days.

How were Aquarius Surgical Technologies Inc.’s earnings last quarter?

Aquarius Surgical Technologies Inc. released its earnings results on Feb 24, 2026. The company reported -C$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.021.

Is Aquarius Surgical Technologies Inc. overvalued?

According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies Inc. pay dividends?

Aquarius Surgical Technologies Inc. does not currently pay dividends.

What is Aquarius Surgical Technologies Inc.’s EPS estimate?

Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies Inc. have?

Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?

Aquarius Surgical Technologies Inc. reported an EPS of -C$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?

Currently, no hedge funds are holding shares in TSE:ASTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies (ASTI) is a pioneering company in the medical device sector, specializing in advanced surgical solutions designed to enhance patient outcomes and streamline surgical procedures. The company focuses on developing innovative technologies for minimally invasive surgeries, including a range of surgical instruments, robotic systems, and imaging solutions that cater to various medical fields such as orthopedics, cardiology, and general surgery. ASTI is committed to improving surgical efficiency and safety through its cutting-edge products and comprehensive support services.